NEKTAR THERAPEUTICS — Director's Dealing 2021

Nov 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2021-11-11

Reporting Person: Brainard Diana (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-11	Common Stock	A	18360	$0.00	Acquired	18360	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-11	Stock Option	$13.55	A	36720	Acquired	2029-11-10	Common Stock (36720)	Direct

Footnotes

F1: Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2: This RSU award vests over three years in equal annual installments beginning on November 11, 2021.

F3: This stock option vests in equal monthly installments over the three-year period beginning on November 11, 2021.